We are live on ! Find out more
AGMB

AgomAb Therapeutics NV

Name Holding Trade Value Shares
Change
Change in
Stake
EFM
1
EQT Fund Management
Luxembourg
$66.7M – – –
S
2
Sanofi
France
$36.1M – – –
RG
3
Redmile Group
California
$35.5M +$29M +2,577,676 +1,650%
CAM
4
Cormorant Asset Management
Massachusetts
$32M – – –
TCM
5
TCG Crossover Management
California
$26.7M – – –
Federated Hermes
6
Federated Hermes
Pennsylvania
$21M – – –
NCM
7
Nantahala Capital Management
Connecticut
$20.4M +$4.14M +368,188 +31%
CC
8
Casdin Capital
New York
$20.1M – – –
AP
9
Andera Partners
$20M – – –
Fidelity Investments
10
Fidelity Investments
Massachusetts
$18.9M – – –
Aberdeen Group
11
Aberdeen Group
United Kingdom
$11M +$1.57M +139,039 +20%
PA
12
Perceptive Advisors
New York
$7.79M – – –
SB
13
Samsara BioCapital
California
$7.79M – – –
SL
14
Siren LLC
Connecticut
$5.34M – – –
O
15
OrbiMed
New York
$2.5M +$2.17M +192,740 New
P
16
Pfizer
New York
$1.04M – – –
AA
17
ALPS Advisors
Colorado
$649K +$563K +49,984 New
BG
18
Bellevue Group
Switzerland
$639K -$8.46K -752 -2%
SGM
19
Seven Grand Managers
New York
$618K -$1.72M -152,400 -76%
SAM
20
Sectoral Asset Management
Quebec, Canada
$565K – – –
BGM
21
Burkehill Global Management
New York
$454K – – –
QC
22
Quadrature Capital
United Kingdom
$266K +$230K +20,461 New
Two Sigma Investments
23
Two Sigma Investments
New York
$235K +$43.1K +3,831 +27%
HF
24
HRT Financial
New York
$221K -$74.9K -6,651 -28%
Goldman Sachs
25
Goldman Sachs
New York
$153K -$269K -23,939 -67%